InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
1
T+90 hit rate
0%
T+90 mean return
-41.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Orford Keith, Directeur Médical. Director active across 1 company, notably Calithera Biosciences, Inc.. Aggregated, 3 reports have been recorded. Breakdown: 0 buy · 1 sell. History available since 27 October 2021. The latest transaction was filed on 5 November 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
30,000 shares@ €0.738650.0% of flowCommon StockSEC:0000899243-21-044426:0
30,000 shares0Common StockSEC:0000899243-21-043693:0
90,000 shares0Common StockSEC:0000899243-21-042070:0
3 of 3 declarations
About Orford Keith
Keith Orford is the Chief Medical Officer and Board Member at Calithera Biosciences, Inc. He oversees the company's medical affairs, ensuring compliance and risk management. His expertise is essential to protect the organization's interests.
